194 related articles for article (PubMed ID: 34641594)
1. Curcumin Loaded Dendrimers Specifically Reduce Viability of Glioblastoma Cell Lines.
Gallien J; Srinageshwar B; Gallo K; Holtgrefe G; Koneru S; Otero PS; Bueno CA; Mosher J; Roh A; Kohtz DS; Swanson D; Sharma A; Dunbar G; Rossignol J
Molecules; 2021 Oct; 26(19):. PubMed ID: 34641594
[TBL] [Abstract][Full Text] [Related]
2. Co-delivery of curcumin and Bcl-2 siRNA by PAMAM dendrimers for enhancement of the therapeutic efficacy in HeLa cancer cells.
Ghaffari M; Dehghan G; Baradaran B; Zarebkohan A; Mansoori B; Soleymani J; Ezzati Nazhad Dolatabadi J; Hamblin MR
Colloids Surf B Biointerfaces; 2020 Apr; 188():110762. PubMed ID: 31911391
[TBL] [Abstract][Full Text] [Related]
3. Targeting Breast Cancer Cells with G4 PAMAM Dendrimers and Valproic Acid Derivative Complexes.
Muñoz AM; Fragoso-Vázquez MJ; Martel BP; Chávez-Blanco A; Dueñas-González A; R García-Sánchez J; Bello M; Romero-Castro A; Correa-Basurto J
Anticancer Agents Med Chem; 2020; 20(15):1857-1872. PubMed ID: 32324521
[TBL] [Abstract][Full Text] [Related]
4. In vitro and in vivo uptake studies of PAMAM G4.5 dendrimers in breast cancer.
Oddone N; Lecot N; Fernández M; Rodriguez-Haralambides A; Cabral P; Cerecetto H; Benech JC
J Nanobiotechnology; 2016 Jun; 14(1):45. PubMed ID: 27297021
[TBL] [Abstract][Full Text] [Related]
5. Poly(amidoamine) Dendrimers as Nanocarriers for 5-Fluorouracil: Effectiveness of Complex Formation and Cytotoxicity Studies.
Szota M; Reczyńska-Kolman K; Pamuła E; Michel O; Kulbacka J; Jachimska B
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681827
[TBL] [Abstract][Full Text] [Related]
6. Arginine-terminated generation 4 PAMAM dendrimer as an effective nanovector for functional siRNA delivery in vitro and in vivo.
Liu C; Liu X; Rocchi P; Qu F; Iovanna JL; Peng L
Bioconjug Chem; 2014 Mar; 25(3):521-32. PubMed ID: 24494983
[TBL] [Abstract][Full Text] [Related]
7. Co-delivery of cisplatin and doxorubicin by covalently conjugating with polyamidoamine dendrimer for enhanced synergistic cancer therapy.
Guo XL; Kang XX; Wang YQ; Zhang XJ; Li CJ; Liu Y; Du LB
Acta Biomater; 2019 Jan; 84():367-377. PubMed ID: 30528609
[TBL] [Abstract][Full Text] [Related]
8. Low systemic toxicity nanocarriers fabricated from heparin-mPEG and PAMAM dendrimers for controlled drug release.
Thanh VM; Nguyen TH; Tran TV; Ngoc UP; Ho MN; Nguyen TT; Chau YNT; Le VT; Tran NQ; Nguyen CK; Nguyen DH
Mater Sci Eng C Mater Biol Appl; 2018 Jan; 82():291-298. PubMed ID: 29025661
[TBL] [Abstract][Full Text] [Related]
9. Anti-inflammatory and anti-oxidant activity of anionic dendrimer-N-acetyl cysteine conjugates in activated microglial cells.
Wang B; Navath RS; Romero R; Kannan S; Kannan R
Int J Pharm; 2009 Jul; 377(1-2):159-68. PubMed ID: 19463931
[TBL] [Abstract][Full Text] [Related]
10. α-Tocopherol Succinate-Anchored PEGylated Poly(amidoamine) Dendrimer for the Delivery of Paclitaxel: Assessment of in Vitro and in Vivo Therapeutic Efficacy.
Bhatt H; Kiran Rompicharla SV; Ghosh B; Biswas S
Mol Pharm; 2019 Apr; 16(4):1541-1554. PubMed ID: 30817166
[TBL] [Abstract][Full Text] [Related]
11. Folic acid-decorated polyamidoamine dendrimer exhibits high tumor uptake and sustained highly localized retention in solid tumors: Its utility for local siRNA delivery.
Xu L; Yeudall WA; Yang H
Acta Biomater; 2017 Jul; 57():251-261. PubMed ID: 28438704
[TBL] [Abstract][Full Text] [Related]
12. Activated and non-activated PAMAM dendrimers for gene delivery in vitro and in vivo.
Navarro G; Tros de Ilarduya C
Nanomedicine; 2009 Sep; 5(3):287-97. PubMed ID: 19523431
[TBL] [Abstract][Full Text] [Related]
13. PAMAM Dendrimer Nanomolecules Utilized as Drug Delivery Systems for Potential Treatment of Glioblastoma: A Systematic Review.
Fana M; Gallien J; Srinageshwar B; Dunbar GL; Rossignol J
Int J Nanomedicine; 2020; 15():2789-2808. PubMed ID: 32368055
[TBL] [Abstract][Full Text] [Related]
14. Permeability of surface-modified polyamidoamine (PAMAM) dendrimers across Caco-2 cell monolayers.
Pisal DS; Yellepeddi VK; Kumar A; Kaushik RS; Hildreth MB; Guan X; Palakurthi S
Int J Pharm; 2008 Feb; 350(1-2):113-21. PubMed ID: 17913410
[TBL] [Abstract][Full Text] [Related]
15. The influence of PAMAM dendrimers surface groups on their interaction with porcine pepsin.
Ciolkowski M; Rozanek M; Bryszewska M; Klajnert B
Biochim Biophys Acta; 2013 Oct; 1834(10):1982-7. PubMed ID: 23851144
[TBL] [Abstract][Full Text] [Related]
16. Dendrimers bind antioxidant polyphenols and cisplatin drug.
Abderrezak A; Bourassa P; Mandeville JS; Sedaghat-Herati R; Tajmir-Riahi HA
PLoS One; 2012; 7(3):e33102. PubMed ID: 22427960
[TBL] [Abstract][Full Text] [Related]
17. PAMAM dendrimers augment inhibitory effects of curcumin on cancer cell proliferation: possible inhibition of telomerase.
Mollazade M; Nejati-Koshki K; Akbarzadeh A; Zarghami N; Nasiri M; Jahanban-Esfahlan R; Alibakhshi A
Asian Pac J Cancer Prev; 2013; 14(11):6925-8. PubMed ID: 24377627
[TBL] [Abstract][Full Text] [Related]
18. Cellular uptake of glucoheptoamidated poly(amidoamine) PAMAM G3 dendrimer with amide-conjugated biotin, a potential carrier of anticancer drugs.
Uram Ł; Szuster M; Filipowicz A; Zaręba M; Wałajtys-Rode E; Wołowiec S
Bioorg Med Chem; 2017 Jan; 25(2):706-713. PubMed ID: 27919613
[TBL] [Abstract][Full Text] [Related]
19. Hyaluronic acid-conjugated polyamidoamine dendrimers for targeted delivery of 3,4-difluorobenzylidene curcumin to CD44 overexpressing pancreatic cancer cells.
Kesharwani P; Xie L; Banerjee S; Mao G; Padhye S; Sarkar FH; Iyer AK
Colloids Surf B Biointerfaces; 2015 Dec; 136():413-23. PubMed ID: 26440757
[TBL] [Abstract][Full Text] [Related]
20. Mitochondria-Targeted Polyamidoamine Dendrimer-Curcumin Construct for Hepatocellular Cancer Treatment.
Kianamiri S; Dinari A; Sadeghizadeh M; Rezaei M; Daraei B; Bahsoun NE; Nomani A
Mol Pharm; 2020 Dec; 17(12):4483-4498. PubMed ID: 33205974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]